Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin
- 4 February 2005
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 327 (1), 225-233
- https://doi.org/10.1016/j.bbrc.2004.12.008
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- DNA repair and cisplatin resistance in non-small-cell lung cancerLung Cancer, 2002
- Nucleotide excision repair and human syndromesCarcinogenesis: Integrative Cancer Research, 2000
- Damage recognition in nucleotide excision repair of DNAGene, 1999
- Single d(GpG)/cis-Diammineplatinum(II) Adduct-Induced Inhibition of DNA PolymerizationBiochemistry, 1998
- Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapyCancer Treatment Reviews, 1998
- Cisplatin and DNA repair in cancer chemotherapyTrends in Biochemical Sciences, 1995
- Excision Repair in Mammalian CellsPublished by Elsevier BV ,1995
- The General Transcription-Repair Factor TFIIH Is Recruited to the Excision Repair Complex by the XPA Protein Independent of the TFIIE Transcription FactorPublished by Elsevier BV ,1995
- An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10Cell, 1986